4//SEC Filing
Auffarth Gerd 4
Accession 0001209191-20-025302
CIK 0001649989other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:38 PM ET
Size
5.5 KB
Accession
0001209191-20-025302
Insider Transaction Report
Form 4
Auffarth Gerd
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-20+25,000→ 25,000 totalExercise: $0.72Exp: 2030-04-20→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option will vest in three equal annual installments such that the stock option will be fully vested as of the third anniversary of the grant date, subject to (x) the Reporting Person's Continuous Service to the Issuer through such vesting date and (y) acceleration upon a Change in Control.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001649867
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 6:38 PM ET
- Size
- 5.5 KB